Re:Branding Breast Cancer

In response to “Branding Breast Cancer”, let me define the breast cancer in general. Breast cancer is a cancer that starts in the cells of the breast in women and men. Worldwide, breast cancer is the second most common type of cancer after lung cancer. The breast is composed of identical tissues in males and females, breast cancer also occur in males. Incidences of breast cancer in men are approximately 100 times less common than in women, but men with breast cancer are considered to have the same statistical survival rates as women. I agree with Kellyeichman that all means necessary should be used in order to raise capital for breast cancer research in order to find cures and treatment for this disease that has many impacted the lives of so many. Nowadays, FEMARA is helping more women than ever before. An international, clinical trial showed that FEMARA is more effective than tamoxifen at reducing the risk of cancer coming back in postmenopausal women with hormone receptor-positive early stage breast cancer based on 24 months of treatment.